Blood Testing Devices Market Growth, Top Key Players, and Regional Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Blood Testing Devices Market covers analysis By Product (Diabetes Analyzer, Coagulation Analyzer, Blood Analyzer, Hematology Analyzer); Test Type (Glucose test, A1C test , Thyroid Function Test, Creatinine Test, Coagulation Test, Full Blood Count, Direct LDL test, and Others); End User (Hospitals & Clinics, Diagnostic Centers, Homecare) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Feb 2026
  • Report Code : TIPHE100001374
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Jan 2025

The Blood Testing Devices Market size is expected to reach US$ 64.55 Billion by 2031. The market is anticipated to register a CAGR of 8.7% during 2025-2031.

The report is segmented by Product (Diabetes Analyzer, Coagulation Analyzer, Blood Analyzer, and Hematology Analyzer), Test Type (Glucose test, A1C test , Thyroid Function Test, Creatinine Test, Coagulation Test, Full Blood Count, Direct LDL test, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, and Homecare). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Blood Testing Devices Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Blood Testing Devices Market Segmentation Product

  1. Diabetes Analyzer
  2. Coagulation Analyzer
  3. Blood Analyzer
  4. Hematology Analyzer

Test Type

  1. Glucose test
  2. A1C test
  3. Thyroid Function Test
  4. Creatinine Test
  5. Coagulation Test
  6. Full Blood Count
  7. Direct LDL test
  8. Others

End User

  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Homecare

Geography

  1. North America
  2. Europe
  3. Asia-Pacific
  4. South and Central America
  5. Middle East and Africa
Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Blood Testing Devices Market: Strategic Insights

blood-testing-devices-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Blood Testing Devices Market Growth Drivers

  1. Increasing prevalence of chronic diseases: In the last 25 years, the incidence of chronic diseases has increased worldwide owing to lifestyle changes, which result in an increase in the number of surgeries. For instance, colorectal cancer is one of the most commonly found and lethal cancers developed in individuals due to the combined influence of genetic and environmental factors. According to the World Health Organization (WHO), colorectal cancer was identified as the third most common cancer and the second highest death-causing cancer, with ~1,926,425 global cases in 2022. The prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disease is increasing globally, leading to a growing need for diagnostic testing.
  2. Growing demand for point-of-care testing: Point-of-care testing (POCT) devices allow physicians or health care providers to administer tests in the patientReport Scope

    Blood Testing Devices Market Regional Insights

    The regional trends and factors influencing the Blood Testing Devices Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Blood Testing Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

    Blood Testing Devices Market Report Scope

    By Test Type
    • Glucose test
    • A1C test
    • Thyroid Function Test
    • Creatinine Test
    • Coagulation Test
    • Full Blood Count
    • Direct LDL test
    • Others
    By End User
    • Hospitals & Clinics
    • Diagnostic Centers
    • Homecare
    Europe
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
    Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
    South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America
    Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
    Report Attribute Details
    Market size in 2024 US$ XX Billion
    Market Size by 2031 US$ 64.55 Billion
    Global CAGR (2025 - 2031) 8.7%
    Historical Data 2021-2023
    Forecast period 2025-2031
    Segments Covered By Product
    • Diabetes Analyzer
    • Coagulation Analyzer
    • Blood Analyzer
    • Hematology Analyzer
    Regions and Countries Covered North America
    • US
    • Canada
    • Mexico
    Market leaders and key company profiles
    • Abbott
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens AG
    • Trinity Biotech Plc.
    • BioMerieux S.A.
    • Luminex Corporation
    • Thermo Fisher Scientific, Inc.
    • Getein Biotech, Inc.

    Blood Testing Devices Market Players Density: Understanding Its Impact on Business Dynamics

    The Blood Testing Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    blood-testing-devices-market-cagr
    • Get the Blood Testing Devices Market top key players overview

Frequently Asked Questions

1

What is the expected CAGR of the blood testing devices market?

The blood testing devices market is estimated to grow with a CAGR of 8.7% from 2025 to 2031.
2

Which region is expected to witness fastest growth rate by 2031?

Asia Pacific region is likely to witness fastest growth rate during the forecast period.
3

What are the driving factors impacting the blood testing devices market?

The market drivers include Increasing prevalence of chronic diseases and Growing demand for point-of-care testing are driving the blood testing devices market
4

Which are the leading players operating in the blood testing devices market?

The blood testing devices market majorly consists of the players such as Abbott Laboratories, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd. among others.
5

What are the future trends of the blood testing devices market?

Advancements in Blood Testing Technology and Increased Focus on Personalized Medicine are likely to remain the key trend during the forecast period
6

Which region dominated the blood testing devices market in 2023?

North America dominated the blood testing devices market in 2023
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA